US approval for migraine treatment

I reported previously (see here) on the AJOVY fremanezumab migraine treatment from Israel’s Teva. The US FDA has just given approval for AJOVY – the only anti-CGRP treatment for the prevention of migraine.  About 40% of migraine sufferers may be candidates for this treatment.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

2 Responses to US approval for migraine treatment

  1. John Rodgers says:

    Is this treatment available in Australia? My daughter has suffered from migraine headaches for many years without finding a cure.

  2. Woodrow Short says:

    I have two friends who suffer from this. Where can we get ti in the USA?

Leave a Reply

Your email address will not be published. Required fields are marked *